Skip to content
跳至主要內容
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
Stock detail
Loading institutional stock data...
← BACK TO COCKPIT
ALL TICKERS →
OPTIONS CHAIN →
ALDX
Aldeyra Therapeutics, Inc.
NASDAQCM
Biotechnology
United States
$1.48
—
+0.00 (+0.00%)
CLOSED
—
OPEN
$1.48
HIGH
$1.49
LOW
$1.46
PREV CLOSE
$1.48
VOLUME
483.9K
0.38x avg
BID / ASK
1.06 / 1.89
spr 0.830
MARKET CAP
$89.3M
DAY RANGE
$1.46
$1.49
P/E (TTM)
—
Fwd -5.4
EPS (TTM)
-0.38
DIV YIELD
—
52W HIGH
$5.93
-75.0%
52W LOW
$1.07
+38.3%
BETA
1.19
vs S&P 500
DES
FA
GP
OPT
HLDR
EARN
CMP
COMPARE
ASK DESK
AFTER-HOURS
$1.5
+0.02
(+1.34%)
LAST SURPRISE
—
—
NEXT EARNINGS
—
—
CATALYST
No fresh catalyst
—
ANALYST
—
—
SHORT INT
—
—
OPTIONS IV
—
—
ALDX
$1.48
▲
+0.00%
Chart
Valuation
Financials
Peers
News
ALDX · K 線技術分析（即時、可互動）
basic
pro
快速分析（約 90–120 秒）
K 線圖載入中…
按上方「快速分析」，研究台會以這張 K 線為起點跑一輪快速回答：三個分析師視角（總經、基本面、技術面）加交易計畫與風險統計，約 90–120 秒。想要五隊深度研究與機構級報告，請在研究台把模式切到「深度」。
1-YEAR PRICE
One-Year Trajectory
RISK-OFF
251 BARS · -73.4% YOY
1-year price chart. Started at 5.56, currently 1.48, down 73.4 percent. Range 1.24 to 5.76 over 251 data points.
2025-09-05
$5.56 → $1.48 (-73.4%)
2026-09-03
§ Valuation
Loading § Valuation
§ Multi-Year Financials
Loading § Multi-Year Financials
§ Peers
Loading § Peers
§ Recent News
Loading § Recent News
EDITORIAL · NOT INVESTMENT ADVICE.
Data sources: Finnhub (quote / profile / news / peers) + Yahoo (stats) + SEC EDGAR XBRL (financials + DCF). All values cached for 5 minutes via ISR.
VALUATION
Deterministic Valuation (SEC EDGAR + Finnhub)
—
NO DCF
DCF Fair Value
—
DCF vs Spot
—
Comps Fair Value
$0.63
WACC Used
+7.0%
Terminal g
+3.5%
Verdict: strong-sell
· peers $0.63 (-57.5%)
Peers:
ACRV
FBIO PE1
ICCC PE141
RLYB PE2
ACET
OSTX
GOSS
KLRS
⚠ DCF skipped: missing FCF or shares data from SEC EDGAR. Often the case for non-US issuers.
FINANCIALS
Multi-Year Financials (SEC XBRL)
—
3 FY · NO YOY
FY
Revenue
Net Income
OCF
FCF
Assets
2025-12
—
-$33.8M
-$33.3M
—
$72.1M
2024-12
—
-$55.9M
-$43.2M
—
$104.6M
2023-12
—
-$37.5M
-$30.3M
-$30.3M
$148.3M
PEERS
Sector & Industry Peers
CALM
10 PEERS · FINNHUB
ACRV
FBIO
ICCC
RLYB
ACET
OSTX
GOSS
KLRS
CRDF
MAIA
NEWS
Recent News (past 14 days)
CALM
10 HEADLINES · LAST 14 DAYS
Krystal Stock Gains 13.4% in a Month: What Is Driving the Rally?
Zacks · 2026-09-03
FDA Accepts UTHR's sNDA for Tyvaso in Idiopathic Pulmonary Fibrosis
Zacks · 2026-09-03
RARE Stock Down 46% as Phase III Angelman Syndrome Study Misses Goals
Zacks · 2026-09-03
Here's Why You Should Add RNTX Stock to Your Portfolio Now
Zacks · 2026-09-03
KURA Stock Gains 37.6% in a Month: Here's What You Need to Know
Zacks · 2026-09-01
Here's Why You Should Add ARQT Stock to Your Portfolio Now
Zacks · 2026-08-28
Gilead Wins FDA Nod for Bixlenvo in Adults Living With HIV Infection
Zacks · 2026-08-28
Aldeyra Therapeutics Seeks FDA Clarification on Reproxalap NDA Meeting Minutes
MT Newswires · 2026-07-16